cas9 protein Search Results


90
Genecopoeia cas9 protein
Cas9 Protein, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cas9+protein/pmc05617676-392-38-59?v=Genecopoeia
Average 90 stars, based on 1 article reviews
cas9 protein - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

94
Sino Biological cas9 protein
Cas9 Protein, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cas9+protein/pmc10811239-549-12-14?v=Sino+Biological
Average 94 stars, based on 1 article reviews
cas9 protein - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

94
Proteintech cas9 protein
Cas9 Protein, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cas9+protein/pm39992014-207-1-8?v=Proteintech
Average 94 stars, based on 1 article reviews
cas9 protein - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

91
OriGene dcas9 protein
Dcas9 Protein, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cas9+protein/pmc10477904-217-17-19?v=OriGene
Average 91 stars, based on 1 article reviews
dcas9 protein - by Bioz Stars, 2026-07
91/100 stars
  Buy from Supplier

93
OriGene cas9 endonuclease
Junctions and replication timing phenotypes of HTD114-derived cell clones with <t> CRISPR/Cas9-mediated </t> disruptions in ASAR6 L1PA2, chromosome 6: 96,206,263–96,212,288 (Feb 2009 [GRCh37/hg19])
Cas9 Endonuclease, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cas9+protein/pmc05800813-258-18-20?v=OriGene
Average 93 stars, based on 1 article reviews
cas9 endonuclease - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

91
Santa Cruz Biotechnology protein 9 crispr cas9 knockout hnrnp a b plasmids
Junctions and replication timing phenotypes of HTD114-derived cell clones with <t> CRISPR/Cas9-mediated </t> disruptions in ASAR6 L1PA2, chromosome 6: 96,206,263–96,212,288 (Feb 2009 [GRCh37/hg19])
Protein 9 Crispr Cas9 Knockout Hnrnp A B Plasmids, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cas9+protein/pmc12266502-134-14-21?v=Santa+Cruz+Biotechnology
Average 91 stars, based on 1 article reviews
protein 9 crispr cas9 knockout hnrnp a b plasmids - by Bioz Stars, 2026-07
91/100 stars
  Buy from Supplier

91
OriGene tp790148
Junctions and replication timing phenotypes of HTD114-derived cell clones with <t> CRISPR/Cas9-mediated </t> disruptions in ASAR6 L1PA2, chromosome 6: 96,206,263–96,212,288 (Feb 2009 [GRCh37/hg19])
Tp790148, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cas9+protein/bio_rxiv__2023__06__08__544271-69-39-38?v=OriGene
Average 91 stars, based on 1 article reviews
tp790148 - by Bioz Stars, 2026-07
91/100 stars
  Buy from Supplier

91
Santa Cruz Biotechnology goat anti rabbit
Junctions and replication timing phenotypes of HTD114-derived cell clones with <t> CRISPR/Cas9-mediated </t> disruptions in ASAR6 L1PA2, chromosome 6: 96,206,263–96,212,288 (Feb 2009 [GRCh37/hg19])
Goat Anti Rabbit, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cas9+protein/pmc07640364-40-6-20?v=Santa+Cruz+Biotechnology
Average 91 stars, based on 1 article reviews
goat anti rabbit - by Bioz Stars, 2026-07
91/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology foxo1 crispr cas9 ko plasmid
Fig. 2 β-catenin/TCF and β- <t>catenin/Foxo1</t> interactions in C1.1 cells. a Representative blots of co-IP for β-catenin or IgG (as a negative control) with TCF or Foxo1 in C1.1 cells. RhTGF-β1 (3 ng/ml) increased β-catenin/TCF binding (1st row, 2nd lane) while rhTGF-β1 and ICG-001 (5 and 10 µM) promoted β-catenin/Foxo1 binding (3rd row, 3rd and 4th lane). Western blots of β-catenin in C1.1 cells of control, rhTGF- β1, rhTGF-β1 + ICG-001 (5 µM), rhTGF-β1 + ICG-001 (10 µM), ICG-001 only. Representative of three independent experiments. b Association of β-catenin/ Foxo1 (red spot) and β-catenin/ TCF (green spot) were demonstrated by PLA in C1.1 cells. Nuclei were stained with DAPI. Representative of three independent experiments. Original magnification, X60. Scale bar, 10 µm. c, d Quantitation of PLA spots (fold change) in C1.1 cells by one- way ANOVA followed by Tukey post hoc test. The relative PLA spots of control were arbitrarily set as one. e The relative Foxo reporter luciferase activities are shown in control C1.1 cells, and F-TrCP-Ecad- transfected, rhTGF-β1 treated, rhTGF-β1 and ICG-001 treated, F-TrCP-Ecad transfected and rhTGF-β1 + ICG-001 treated, ICG-001 alone treated C1.1 cells. f β-catenin/TCF activity shown by TOP-Flash assay in C1.1 cells with the various treatments described. Data are representative results of at least three independent experiments performed in triplicate. Quantitation of relative luciferase activity is shown as fold increase in luciferase activity. The control was arbitrarily defined as one. Results are shown as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001
Foxo1 Crispr Cas9 Ko Plasmid, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cas9+protein/pm31243340-26-22-31?v=Santa+Cruz+Biotechnology
Average 92 stars, based on 1 article reviews
foxo1 crispr cas9 ko plasmid - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology protein 9 crispr cas9 system
Fig. 2 β-catenin/TCF and β- <t>catenin/Foxo1</t> interactions in C1.1 cells. a Representative blots of co-IP for β-catenin or IgG (as a negative control) with TCF or Foxo1 in C1.1 cells. RhTGF-β1 (3 ng/ml) increased β-catenin/TCF binding (1st row, 2nd lane) while rhTGF-β1 and ICG-001 (5 and 10 µM) promoted β-catenin/Foxo1 binding (3rd row, 3rd and 4th lane). Western blots of β-catenin in C1.1 cells of control, rhTGF- β1, rhTGF-β1 + ICG-001 (5 µM), rhTGF-β1 + ICG-001 (10 µM), ICG-001 only. Representative of three independent experiments. b Association of β-catenin/ Foxo1 (red spot) and β-catenin/ TCF (green spot) were demonstrated by PLA in C1.1 cells. Nuclei were stained with DAPI. Representative of three independent experiments. Original magnification, X60. Scale bar, 10 µm. c, d Quantitation of PLA spots (fold change) in C1.1 cells by one- way ANOVA followed by Tukey post hoc test. The relative PLA spots of control were arbitrarily set as one. e The relative Foxo reporter luciferase activities are shown in control C1.1 cells, and F-TrCP-Ecad- transfected, rhTGF-β1 treated, rhTGF-β1 and ICG-001 treated, F-TrCP-Ecad transfected and rhTGF-β1 + ICG-001 treated, ICG-001 alone treated C1.1 cells. f β-catenin/TCF activity shown by TOP-Flash assay in C1.1 cells with the various treatments described. Data are representative results of at least three independent experiments performed in triplicate. Quantitation of relative luciferase activity is shown as fold increase in luciferase activity. The control was arbitrarily defined as one. Results are shown as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001
Protein 9 Crispr Cas9 System, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cas9+protein/pmc06593428-26-7-20?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
protein 9 crispr cas9 system - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology human txnip crispr cas9 ko plasmid
Fig. 2 β-catenin/TCF and β- <t>catenin/Foxo1</t> interactions in C1.1 cells. a Representative blots of co-IP for β-catenin or IgG (as a negative control) with TCF or Foxo1 in C1.1 cells. RhTGF-β1 (3 ng/ml) increased β-catenin/TCF binding (1st row, 2nd lane) while rhTGF-β1 and ICG-001 (5 and 10 µM) promoted β-catenin/Foxo1 binding (3rd row, 3rd and 4th lane). Western blots of β-catenin in C1.1 cells of control, rhTGF- β1, rhTGF-β1 + ICG-001 (5 µM), rhTGF-β1 + ICG-001 (10 µM), ICG-001 only. Representative of three independent experiments. b Association of β-catenin/ Foxo1 (red spot) and β-catenin/ TCF (green spot) were demonstrated by PLA in C1.1 cells. Nuclei were stained with DAPI. Representative of three independent experiments. Original magnification, X60. Scale bar, 10 µm. c, d Quantitation of PLA spots (fold change) in C1.1 cells by one- way ANOVA followed by Tukey post hoc test. The relative PLA spots of control were arbitrarily set as one. e The relative Foxo reporter luciferase activities are shown in control C1.1 cells, and F-TrCP-Ecad- transfected, rhTGF-β1 treated, rhTGF-β1 and ICG-001 treated, F-TrCP-Ecad transfected and rhTGF-β1 + ICG-001 treated, ICG-001 alone treated C1.1 cells. f β-catenin/TCF activity shown by TOP-Flash assay in C1.1 cells with the various treatments described. Data are representative results of at least three independent experiments performed in triplicate. Quantitation of relative luciferase activity is shown as fold increase in luciferase activity. The control was arbitrarily defined as one. Results are shown as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001
Human Txnip Crispr Cas9 Ko Plasmid, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cas9+protein/bio_rxiv__2022__08__04__502753-219-5-19?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 1 article reviews
human txnip crispr cas9 ko plasmid - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
GenScript corporation p62-specific crispr/cas9 plasmids
Fig. 2 β-catenin/TCF and β- <t>catenin/Foxo1</t> interactions in C1.1 cells. a Representative blots of co-IP for β-catenin or IgG (as a negative control) with TCF or Foxo1 in C1.1 cells. RhTGF-β1 (3 ng/ml) increased β-catenin/TCF binding (1st row, 2nd lane) while rhTGF-β1 and ICG-001 (5 and 10 µM) promoted β-catenin/Foxo1 binding (3rd row, 3rd and 4th lane). Western blots of β-catenin in C1.1 cells of control, rhTGF- β1, rhTGF-β1 + ICG-001 (5 µM), rhTGF-β1 + ICG-001 (10 µM), ICG-001 only. Representative of three independent experiments. b Association of β-catenin/ Foxo1 (red spot) and β-catenin/ TCF (green spot) were demonstrated by PLA in C1.1 cells. Nuclei were stained with DAPI. Representative of three independent experiments. Original magnification, X60. Scale bar, 10 µm. c, d Quantitation of PLA spots (fold change) in C1.1 cells by one- way ANOVA followed by Tukey post hoc test. The relative PLA spots of control were arbitrarily set as one. e The relative Foxo reporter luciferase activities are shown in control C1.1 cells, and F-TrCP-Ecad- transfected, rhTGF-β1 treated, rhTGF-β1 and ICG-001 treated, F-TrCP-Ecad transfected and rhTGF-β1 + ICG-001 treated, ICG-001 alone treated C1.1 cells. f β-catenin/TCF activity shown by TOP-Flash assay in C1.1 cells with the various treatments described. Data are representative results of at least three independent experiments performed in triplicate. Quantitation of relative luciferase activity is shown as fold increase in luciferase activity. The control was arbitrarily defined as one. Results are shown as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001
P62 Specific Crispr/Cas9 Plasmids, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cas9+protein/pmc09263135-29-0-6?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
p62-specific crispr/cas9 plasmids - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Junctions and replication timing phenotypes of HTD114-derived cell clones with  CRISPR/Cas9-mediated  disruptions in ASAR6 L1PA2, chromosome 6: 96,206,263–96,212,288 (Feb 2009 [GRCh37/hg19])

Journal: The Journal of Cell Biology

Article Title: L1 retrotransposon antisense RNA within ASAR lncRNAs controls chromosome-wide replication timing

doi: 10.1083/jcb.201707082

Figure Lengend Snippet: Junctions and replication timing phenotypes of HTD114-derived cell clones with CRISPR/Cas9-mediated disruptions in ASAR6 L1PA2, chromosome 6: 96,206,263–96,212,288 (Feb 2009 [GRCh37/hg19])

Article Snippet: Using Lipofectamine 2000 according to the manufacturer’s recommendations, we cotransfected HTD114 cells with plasmids encoding GFP, sgRNAs, and Cas9 endonuclease (Origene).

Techniques: Clone Assay, CRISPR

Fig. 2 β-catenin/TCF and β- catenin/Foxo1 interactions in C1.1 cells. a Representative blots of co-IP for β-catenin or IgG (as a negative control) with TCF or Foxo1 in C1.1 cells. RhTGF-β1 (3 ng/ml) increased β-catenin/TCF binding (1st row, 2nd lane) while rhTGF-β1 and ICG-001 (5 and 10 µM) promoted β-catenin/Foxo1 binding (3rd row, 3rd and 4th lane). Western blots of β-catenin in C1.1 cells of control, rhTGF- β1, rhTGF-β1 + ICG-001 (5 µM), rhTGF-β1 + ICG-001 (10 µM), ICG-001 only. Representative of three independent experiments. b Association of β-catenin/ Foxo1 (red spot) and β-catenin/ TCF (green spot) were demonstrated by PLA in C1.1 cells. Nuclei were stained with DAPI. Representative of three independent experiments. Original magnification, X60. Scale bar, 10 µm. c, d Quantitation of PLA spots (fold change) in C1.1 cells by one- way ANOVA followed by Tukey post hoc test. The relative PLA spots of control were arbitrarily set as one. e The relative Foxo reporter luciferase activities are shown in control C1.1 cells, and F-TrCP-Ecad- transfected, rhTGF-β1 treated, rhTGF-β1 and ICG-001 treated, F-TrCP-Ecad transfected and rhTGF-β1 + ICG-001 treated, ICG-001 alone treated C1.1 cells. f β-catenin/TCF activity shown by TOP-Flash assay in C1.1 cells with the various treatments described. Data are representative results of at least three independent experiments performed in triplicate. Quantitation of relative luciferase activity is shown as fold increase in luciferase activity. The control was arbitrarily defined as one. Results are shown as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001

Journal: Laboratory investigation; a journal of technical methods and pathology

Article Title: Promotion of β-catenin/Foxo1 signaling ameliorates renal interstitial fibrosis.

doi: 10.1038/s41374-019-0276-z

Figure Lengend Snippet: Fig. 2 β-catenin/TCF and β- catenin/Foxo1 interactions in C1.1 cells. a Representative blots of co-IP for β-catenin or IgG (as a negative control) with TCF or Foxo1 in C1.1 cells. RhTGF-β1 (3 ng/ml) increased β-catenin/TCF binding (1st row, 2nd lane) while rhTGF-β1 and ICG-001 (5 and 10 µM) promoted β-catenin/Foxo1 binding (3rd row, 3rd and 4th lane). Western blots of β-catenin in C1.1 cells of control, rhTGF- β1, rhTGF-β1 + ICG-001 (5 µM), rhTGF-β1 + ICG-001 (10 µM), ICG-001 only. Representative of three independent experiments. b Association of β-catenin/ Foxo1 (red spot) and β-catenin/ TCF (green spot) were demonstrated by PLA in C1.1 cells. Nuclei were stained with DAPI. Representative of three independent experiments. Original magnification, X60. Scale bar, 10 µm. c, d Quantitation of PLA spots (fold change) in C1.1 cells by one- way ANOVA followed by Tukey post hoc test. The relative PLA spots of control were arbitrarily set as one. e The relative Foxo reporter luciferase activities are shown in control C1.1 cells, and F-TrCP-Ecad- transfected, rhTGF-β1 treated, rhTGF-β1 and ICG-001 treated, F-TrCP-Ecad transfected and rhTGF-β1 + ICG-001 treated, ICG-001 alone treated C1.1 cells. f β-catenin/TCF activity shown by TOP-Flash assay in C1.1 cells with the various treatments described. Data are representative results of at least three independent experiments performed in triplicate. Quantitation of relative luciferase activity is shown as fold increase in luciferase activity. The control was arbitrarily defined as one. Results are shown as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001

Article Snippet: Generation of Foxo1 KO cell line and TCF1 KO cell line by CRISPR/cas9 To generate Foxo1 KO C1.1 cell lines, we co-transfected Foxo1 CRISPR/cas9 KO plasmid with a Foxo1 HDR plasmid (Santa Cruz Biotechnology, Inc), following the manufacturer’s instructions.

Techniques: Co-Immunoprecipitation Assay, Negative Control, Binding Assay, Western Blot, Control, Staining, Quantitation Assay, Luciferase, Transfection, Activity Assay